TRacheostomy in DElphi for iNTensive Care' (TRiDENT)
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversita degli Studi di Genova
About this trial
The aim of this study is to develop international consensus-based recommendations for tracheostomy care in critically ill patients. Using the Delphi method, the study seeks to identify key practices in post-tracheostomy management, including tube downsizing and decannulation strategies, infection prevention and site care, restoration of communication and swallowing, and the recognition and management of tracheostomy-related complications. By engaging a multidisciplinary panel of international experts involved in tracheostomy care, the study aims to reduce variability in current practice and support the development of standardized, evidence-informed approaches across different clinical settings.
Eligibility criteria
Qualifiers
A minimum of 5 years of clinical experience treating patients requiring tracheostomy and leadership in the subject area.
At least 5 publications in the area.
Disqualifiers
Not more than 70% of the panellists are of the same gender and from each of high and low-middle-income countries
Trial design
Treatments tested in this trial
- Delphi Consensus Process
Treatment groups
No treatment groups listed
Locations
Sponsors and collaborators
Universita degli Studi di Genova
Lead sponsor
University of Michigan
Collaborator
The Royal Wolverhampton Hospitals NHS Trust
Collaborator
Hospital Israelita Albert Einstein
Collaborator
Amsterdam University of Applied Sciences
Collaborator
Tribhuvan University Teaching Hospital, Institute Of Medicine.
Collaborator
The University of Queensland
Collaborator
Federico II University
Collaborator
University of Birmingham
Collaborator
University of Oxford
Collaborator
University Wien
Collaborator
Monash University
Collaborator
Source ClinicalTrials.gov